Skip Nav Destination
Issues
Commentary
Research Articles
Sputum Cytological Atypia as a Predictor of Incident Lung Cancer in a Cohort of Heavy Smokers with Airflow Obstruction1
Sheila A. Prindiville; Tim Byers; Fred R. Hirsch; Wilbur A. Franklin; York E. Miller; Kieu O. Vu; Holly J. Wolf; Anna E. Barón; Kenneth R. Shroyer; Chan Zeng; Tim C. Kennedy; Paul A. Bunn
Environmental and Genetic Determinants of Tobacco Use: Methodology for a Multidisciplinary, Longitudinal Family-Based Investigation1
Gary E. Swan; Karen Suchanek Hudmon; Lisa M. Jack; Kymberli Hemberger; Dorit Carmelli; Taline V. Khroyan; Huijun Z. Ring; Hyman Hops; Judy A. Andrews; Elizabeth Tildesley; Dale McBride; Neal Benowitz; Chris Webster; Kirk C. Wilhelmsen; Heidi S. Feiler; Barbara Koenig; Lorraine Caron; Judy Illes; Li S-C. Cheng
The I1307K Adenomatous Polyposis Coli Gene Variant Does Not Contribute in the Assessment of the Risk for Colorectal Cancer in Ashkenazi Jews1
Hana Strul; Erez Barenboim; Moshe Leshno; Myra Gartner; Revital Kariv; Eli Aljadeff; Yonathan Aljadeff; Dina Kazanov; Ludmila Strier; Andre Keidar; Yehudit Knaani; Yaara Degani; Limor Alon-Baron; Hadas Sobol-Dvory; Zamir Halpern; Nadir Arber
Short Communications
Letters to the Editor
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.